PT Kalbe Farma Tbk
No trades
No trades
Compare with Kalbe Farma
80 IDR
3.66 T IDR
35.32 T IDR
17.41 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Bernadette Ruth Setiady
Website
Headquarters
Jakarta
Founded
1966
IPO date
Jul 30, 1991
ISIN
ID1000125107
FIGI
BBG000BFRVS5
Identifiers
ISIN ID1000125107
PT Kalbe Farma Tbk is engaged in the development, distribution, and trading of pharmaceutical products. It operates through the following divisions: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical division offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health division includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals division sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic division maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of KLBF is 760 IDR — it has increased by 2.72% in the past 24 hours. Watch PT Kalbe Farma Tbk stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange PT Kalbe Farma Tbk stocks are traded under the ticker KLBF.
KLBF stock has fallen by −3.82% compared to the previous week, the month change is a −6.21% fall, over the last year PT Kalbe Farma Tbk has showed a −35.59% decrease.
We've gathered analysts' opinions on PT Kalbe Farma Tbk future price: according to them, KLBF price has a max estimate of 1,700.00 IDR and a min estimate of 820.00 IDR. Watch KLBF chart and read a more detailed PT Kalbe Farma Tbk stock forecast: see what analysts think of PT Kalbe Farma Tbk and suggest that you do with its stocks.
KLBF reached its all-time high on Feb 13, 2023 with the price of 2,360 IDR, and its all-time low was 70 IDR and was reached on Oct 28, 2008. View more price dynamics on KLBF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KLBF stock is 2.65% volatile and has beta coefficient of 0.50. Track PT Kalbe Farma Tbk stock price on the chart and check out the list of the most volatile stocks — is PT Kalbe Farma Tbk there?
Today PT Kalbe Farma Tbk has the market capitalization of 33.26 T, it has decreased by −6.21% over the last week.
Yes, you can track PT Kalbe Farma Tbk financials in yearly and quarterly reports right on TradingView.
PT Kalbe Farma Tbk is going to release the next earnings report on Nov 3, 2026. Keep track of upcoming events with our Earnings Calendar.
KLBF earnings for the last quarter are 19.14 IDR per share, whereas the estimation was 20.14 IDR resulting in a −4.99% surprise. The estimated earnings for the next quarter are 17.06 IDR per share. See more details about PT Kalbe Farma Tbk earnings.
KLBF net income for the last quarter is 890.54 B IDR, while the quarter before that showed 1.03 T IDR of net income which accounts for 0.00% change. Track more PT Kalbe Farma Tbk financial stats to get the full picture.
Yes, KLBF dividends are paid annually. The last dividend per share was 20.00 IDR. As of today, Dividend Yield (TTM)% is 2.72%. Tracking PT Kalbe Farma Tbk dividends might help you take more informed decisions.
PT Kalbe Farma Tbk dividend yield was 1.66% in 2025, and payout ratio reached 24.84%. The year before the numbers were 2.65% and 51.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 16, 2026, the company has 12.84 K employees. See our rating of the largest employees — is PT Kalbe Farma Tbk on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PT Kalbe Farma Tbk EBITDA is 5.38 T IDR, and current EBITDA margin is 15.14%. See more stats in PT Kalbe Farma Tbk financial statements.
Like other stocks, KLBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PT Kalbe Farma Tbk stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PT Kalbe Farma Tbk technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PT Kalbe Farma Tbk stock shows the sell signal. See more of PT Kalbe Farma Tbk technicals for a more comprehensive analysis.